Montelukast use over the past 20 years: monitoring of its effects and safety issues
Yong Ju Lee, Chang-Keun Kim
Clin Exp Pediatr. 2020;63(10):376-381.   Published online 2020 Feb 5     DOI: https://doi.org/10.3345/cep.2019.00325
Citations to this article as recorded by Crossref logo
Montelukast does not increase the risk of attention-deficit/hyperactivity disorder in pediatric asthma patients: A nationwide population-based matched cohort study
Po-Yu Huang, Yao-Hsu Yang, Ying-Hua Huang, Ho-Chang Kuo, Liang-Jen Wang, Shao-Ju Chien, Ling-Sai Chang
Journal of the Formosan Medical Association.2021; 120(6): 1369.     CrossRef
Huanglong Antitussive Granule Relieves Acute Asthma Through Regulating Pulmonary Lipid Homeostasis
Hua Yan, Guiying Qian, Rui Yang, Zichen Luo, Xianzheng Wang, Tong Xie, Xia Zhao, Jinjun Shan
Frontiers in Pharmacology.2021;[Epub]     CrossRef
Risk of Neuropsychiatric Diseases According to the use of a Leukotriene Receptor Antagonist in Middle-Aged and Older Adults with Asthma: a Nationwide Population-Based Study Using Health Claims Data in Korea
Ji-Su Shim, Min-Hye Kim, Min-Ho Kim, Young-Joo Cho, Eun Mi Chun
The Journal of Allergy and Clinical Immunology: In.2021;[Epub]     CrossRef
Should we prescribe montelukast to allergic pediatric patients?
Yong Mean Park
Clinical and Experimental Pediatrics.2020; 63(10): 389.     CrossRef